Sponsor

Hospital Universitari de Bellvitge

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Hospital Universitari de Bellvitge appears in 47 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials47
Recruiting shown8
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

47 shown
Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with AsthmaNCT06116292 · lead sponsor · 2024-01-01
RECRUITING
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast CancerNCT04889924 · lead sponsor · 2021-06-11
RECRUITING
TAD After Chemotherapy in Locally Advanced Breast CancerNCT05763641 · lead sponsor · 2021-02-01
RECRUITING
ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant ChemotherapyNCT06339658 · lead sponsor · 2021-01-01
RECRUITING
Impact of Systematic Shaving on MarginsNCT05782686 · lead sponsor · 2020-10-07
RECRUITING
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial CancerNCT07462663 · lead sponsor · 2027-01-01
NOT_YET_RECRUITING
Impact of the ARM Technique on the Prevention of Lymphedema After Axillary Lymphadenectomy: A Multicenter Randomized Clinical TrialNCT07515300 · lead sponsor · 2026-03-01
ACTIVE_NOT_RECRUITING
Effect on Body Weight Reduction of a Behavioral Intervention on Lifestyle Using a Digital Nutritional Program in People Living With HIV and Metabolic Dysfunction-associated Steatotic Liver DiseaseNCT07456332 · lead sponsor · 2025-04-23
ENROLLING_BY_INVITATION
Oscillometry in the COPD Exacerbator Phenotype With Triple Inhaled Therapy StudyNCT06931899 · lead sponsor · 2025-04-01
NOT_YET_RECRUITING
EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM)NCT06499064 · lead sponsor · 2024-12-01
UNKNOWN
SIRAKI 02 Posthoc Analysis.NCT06781294 · lead sponsor · 2024-10-01
ACTIVE_NOT_RECRUITING
Validation of a Score for Supplementation Needs of Vitamins, Micronutrients and Proteins After Bariatric SurgeryNCT07268209 · lead sponsor · 2024-06-12
COMPLETED
Diabetes Remission and Hypoabsorptive Bariatric SurgeryNCT06043245 · lead sponsor · 2023-06-21
ENROLLING_BY_INVITATION
Efficacy of a Mobile Application to Help in Weight Loss Before Bariatric SurgeryNCT05598840 · lead sponsor · 2022-10-18
COMPLETED
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE StudyNCT05679713 · lead sponsor · 2022-09-05
UNKNOWN
Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major DepressionNCT05063604 · lead sponsor · 2022-05-10
TERMINATED
Design and Validation of a Preoperative Calculator for "Textbook Outcome" After Bariatric Surgery (BARCINO)NCT06044116 · lead sponsor · 2022-01-01
UNKNOWN
New Pathophysiological Pathways Involved in Iron Metabolism Disorder in Heart FailureNCT05000853 · lead sponsor · 2021-08-01
UNKNOWN
Axillary Reverse Mapping in Breast CancerNCT05040685 · lead sponsor · 2021-06-01
COMPLETED
Comparison of Three Hypoabsortive Surgical Techniques for Treatment of Type IV Morbid ObesityNCT04861961 · lead sponsor · 2021-04-06
COMPLETED
Radiofrequency Ablation (RFA) in Breast TumorsNCT04389216 · lead sponsor · 2020-05-01
COMPLETED
Impact of Socio Economic Limitations on Health Outcomes in Patients With Recent Admission for Heart FailureNCT04022122 · lead sponsor · 2019-07-15
COMPLETED
Cost-effectiveness Study of a Lifestyle Change Program for the Treatment of OSA and Obesity: Hospital-Primary Care.NCT04296721 · lead sponsor · 2019-01-01
COMPLETED
Heart Failure Events Reduction With Remote Monitoring and eHealth Support Investigator Initiated TrialNCT03663907 · lead sponsor · 2018-05-15
COMPLETED
Safety of an Early Discharge Protocol After Sleeve GastrectomyNCT03070457 · lead sponsor · 2017-03-01
UNKNOWN
Effectiveness of an Intensive Weight Loss Program for Obstructive Sleep Apnea Syndrome (OSAS) Treatment.NCT02832414 · lead sponsor · 2016-07-01
COMPLETED
E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSMNCT03357991 · lead sponsor · 2015-01-11
UNKNOWN
Radiofrequency Ablation in Breast CancerNCT02281812 · lead sponsor · 2013-09-01
TERMINATED
Big Data to Assess the Healthcare and Health Outcomes Burden of Acute Coronary Syndromes Complicated With Heart FailureNCT06255418 · lead sponsor · 2012-01-01
COMPLETED
Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major DepressionNCT01305707 · lead sponsor · 2009-07-01
TERMINATED
Impact of Obstructive Sleep Apnea Syndrome on Metabolic Syndrome in Severe ObesityNCT01029561 · lead sponsor · 2009-01-01
UNKNOWN
Prospective Randomized Trial Comparing Two Techniques of Sleeve GastrectomyNCT00793728 · lead sponsor · 2008-10-01
COMPLETED
Trial Comparing Early Complications of Two Techniques in the Laparoscopic Gastric BypassNCT00632593 · lead sponsor · 2005-03-01
COMPLETED
Home tDCS for the Treatment of Major Depression.NCT07510880 · collaborator · 2026-04-14
RECRUITING
ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart FailureNCT07484009 · collaborator · 2026-01-29
RECRUITING
Withdrawal of Heart Failure Treatment Patients With Non-ischemic Cardiomyopathy Who Have Been Super-responders to Cardiac Resynchronization Therapy.NCT07851779 · collaborator · 2026-01-14
RECRUITING
Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and InsomniaNCT07555743 · collaborator · 2026-04-01
NOT_YET_RECRUITING
Proof of Concept of the Aiinane Preoperative Risk Assessment Tool.NCT07021235 · collaborator · 2025-03-03
COMPLETED
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.NCT06434753 · collaborator · 2022-10-02
UNKNOWN
Bariatric Surgery in Patients With SchizophreniaNCT06043206 · collaborator · 2022-10-01
COMPLETED
Respiratory Microbiome and COPD Exacerbations (RESMECOPD)NCT03432234 · collaborator · 2016-03-07
UNKNOWN
Determinants of Onset and Progression of COPD in Young AdultsNCT02352220 · collaborator · 2015-01-01
UNKNOWN
New Treatment Modalities for Localized Prostate CancerNCT05523856 · collaborator · 2014-04-01
ACTIVE_NOT_RECRUITING
Development of Clinical Prediction Rules and Health Services Research in Patients With Heart FailureNCT03512704 · collaborator · 2013-10-01
COMPLETED
Lung Water by Ultrasound Guided Treatment in Hemodialysis Patients (The Lust Study).NCT02310061 · collaborator · 2013-03-01
COMPLETED
Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid TumorsNCT01548924 · collaborator · 2012-04-01
TERMINATED
Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging CorrelatesNCT01484080 · collaborator · 2011-10-01
COMPLETED

Drugs studied in this sponsor's trials

5 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Hospital Universitari de Bellvitge as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
citalopram1
daridorexant 50 MG1
ferric carboxymaltose1
paclitaxel1
placebo1
citalopram RxCUI 2556 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial daridorexant 50 MG RxCUI 2599095 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial ferric carboxymaltose RxCUI 1433693 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial paclitaxel RxCUI 56946 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor33
collaborator14
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.